Opinion: Outing Melanoma
24 February 2016
Melanoma strikes Susie Maroney. An Australian golden girl who made the seas her element has the misfortune to encounter an Australian fact of life and one of our best-kept national secrets. We have the world’s highest rates of melanoma, 12 times the global average. The tragedy is that melanoma is 95% preventable, but we in Australia have a passionate love affair with the sun and just don’t like to talk about the downside. At 41, Susie is young, a mother with three children who needs to have many years ahead of her. She has overcome many obstacles in her life thus far and we hope melanoma will simply be another one.
Treatment for melanoma, the most dangerous form of skin cancer, has made marathon progress in the past five years, much of it led by Australian clinicians and researchers at Melanoma Institute Australia. Previously, the only treatment for melanoma was surgery. Today, immunotherapy, targeted therapy and radiotherapy have claimed their places as additional disciplines. A tripling of life expectancy has been achieved for people with advanced disease. While the research effort turbocharges, to prevent melanoma we have to go back to the basics.
If there is one message we would like to reach the public, it is that melanoma is the most common cancer amongst 15-39 year olds. And in 20-34 year olds it kills more young Australians than any other cancer. No one is bullet-proof. Melanoma can manifest anywhere: it’s not always a changing mole on your back, such as Susie found. It can appear on the soles of your feet, the palms of your hands, under the hair on your scalp, even under a toenail or a tattoo. And you won’t know it’s there.
An Omnipoll we recently commissioned revealed that 39 percent of Australians aged 18–34 have never had a skin check and 78% have not had one in the past year. If you’re over 20 in Australia today, you should have an initial skin check by a GP or at a skin check clinic. They can then advise, based on your personal risk factors, how often your skin needs to be checked from head to toe in the future. If melanoma is caught early, it is now very treatable.
At 17, Susie was the youngest swimmer to cross the English Channel both ways and went on to capture many more records. She has declared that during her many, many kilometres in the ocean, she did not wear sunscreen. Regular use of sunscreen and covering up with UV-protective fabrics goes a long way. On land, broad-brimmed hats and wrap-around sunglasses also help as does taking shelter in shade.
Let’s bring melanoma out of the shadows.
Chief Executive Officer, Melanoma Institute Australia
On Friday, a publication that lays out the steps needed to find out if a systematic screening program for melanoma would benefit all Australians was published in the Australia & New Zealand Journal of Public Health.
Melanoma March events have been cancelled. A Virtual March will be held on Sunday 29th March. Read this statement from MIA CEO Matthew Browne.
Thank you to the thousands of Aussies who bought ‘Game On Mole‘ t-shirts, took selfies, shared t-shirt pics on social media and started lifesaving conversations around sun safety and skin health.
Melanoma patients now have greater access to subsidised immunotherapy thanks to additional treatments today being listed on the PBS.
Brisbane couple Leon and Tamra Betts were, like thousands of others around Australia, on the couch watching MAFS when newlywed Natasha ran through her weekly beauty routine. When they heard the 26-year-old mention solarium use, they were shocked, and then saddened, prompting this open letter to all young Australians.
Professor Richard Scolyer, Co-Medical Director of Melanoma Institute Australia, will welcome international attendees this weekend to a sold-out, two-day course on ‘Pigmented Lesions and Other Hot Topics in Dermatopathology’.
It is time for a reality check on solariums.
They have no place in anyone’s beauty routine.
Throughout January our community created, hosted and participated in some amazing events, each of them helping us on our quest to reach zero deaths from melanoma.
Australian television presenter, interior designer and mother Kyly Clarke has been announced as the new Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign Melanoma March.
Melanoma Institute Australia has recently partnered with three other organisations to boost support for melanoma patients and their carers across Australia.
Melanoma patients and their families across Western Australia will benefit from strengthened and expanded services with the merging of melanomaWA and Melanoma Institute Australia.
Australian researchers have played a critical role in the discovery of a potential new test to predict which early stage melanoma patients are at high risk of their disease recurring and progressing.
We are extremely grateful for our community fundraisers, who, even in this difficult time, have given up their time and effort to fundraise so we can continue to work towards our goal of zero deaths from melanoma.
Melanoma patients are set to benefit from subsidised access to immunotherapy treatment for high risk early-stage and advanced-stage melanoma patients.
An informative article on how immunotherapy is revolutionising cancer treatment, written by Jill Margo and featured in the Australian Financial Review.
Melanoma patients and their families in the Riverina will benefit from strengthened and sustained melanoma services with the merger of the Amie St Clair Melanoma Trust and Melanoma Institute Australia.
Belmont High School at Lake Macquarie has been announced winner of the 2019 SunSafe Student Ambassador Program video competition.
It’s time again to say thank you to our amazing community fundraisers!
Videos of the sessions at the recent Patient Information Evening co-hosted by Melanoma Institute Australia (MIA) and Melanoma Patients Australia (MPA) are now available for viewing.
MIA is well-represented in the poster sessions at the Society for Melanoma Research 2019 Congress in the USA, with four poster presentations being given by members of our translational research lab.